Results 11 to 20 of about 5,533 (163)
New recommendations and opinions released in Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases—2023, as compared with Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases issued in 2017. Abstract Since the four working groups of the Chinese Society of Cardiology issued first
Wenqiang Chen+16 more
wiley +1 more source
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and nearly 6000 interactions with about 3900 ligands.
Stephen P. H. Alexander+27 more
wiley +1 more source
Viscoelastic testing: Critical appraisal of new methodologies and current literature
Abstract United States Food and Drug Administration (FDA)‐approved viscoelastic testing (VET) methodologies have significantly changed in the last 10 years, with the availability of cartridge‐based VET. Some of these cartridge‐based methodologies use harmonic resonance‐based clot detection.
Geoffrey D. Wool, Timothy Carll
wiley +1 more source
Abstract Acute megakaryoblastic leukaemia (AMkL) is a rare subtype of acute myeloid leukaemia (AML) representing 5% of all reported cases, and frequently diagnosed in children with Down syndrome. Patients diagnosed with AMkL have low overall survival and have poor outcome to treatment, thus novel therapies such as CAR T cell therapy could represent an ...
Adrian Bogdan Tigu+22 more
wiley +1 more source
Shear‐Responsive Drug Delivery Systems in Medical Devices: Focus on Thrombosis and Bleeding
This review explores the risk of thrombus formation in blood‐contacting medical devices, and the use of antithrombotic drugs to reduce the risk while balancing the risk of bleeding complications. The potential of the shear‐responsive nanomedicine‐based drug delivery systems for targeted antithrombotic therapy is investigated.
Saeedreza Zeibi Shirejini+4 more
wiley +1 more source
Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab.
Selim Kul, Muhammet Raşit Sayın
doaj +1 more source
Background The significant reduction of angiographic restenosis rates in the ISAR-SWEET study (intracoronary stenting and antithrombotic regimen: is abciximab a superior way to eliminate elevated thrombotic risk in diabetes) raises the question of ...
Baur Regine+4 more
doaj +1 more source
Platelet glycoprotein IIb/IIIa inhibitors (GPIs) have been part of the adjuvant treatment of acute coronary syndrome for years. However, real-life data regarding the efficacy and safety of GPIs under the current indications are lacking in the setting of ...
Pablo Revilla-Martí+8 more
doaj +1 more source
Background Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction.
Gu Youlan L+6 more
doaj +1 more source
FLOW DIVERTER DEVICE IN THE ACUTE SETTING OF RUPTURED BLISTER LIKE ANEURYSM: A CASE REPORT [PDF]
Blister-like aneurysms (BLA) are a rare half-dome-shaped aneurysm, with a broad-based appearance, originating more often from a non-branching site of the supraclinoid internal carotid artery (ICA).
Cesare Gaglaiardo
doaj +1 more source